Harborside


Australis Capital Inc.

CNSX: AUSA


Canadian symbol: AUSA.CN
US symbol: AUSAF

Currency in CAD

Valuation Measures

Market Cap (intraday) 547.72M
Enterprise Value 340.25M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)153.79
Price/Book (mrq)1.60
Enterprise Value/Revenue 3129.71
Enterprise Value/EBITDA 7-3.11

Trading Information

Stock Price History

Beta (5Y Monthly) 1.77
52-Week Change 358.82%
S&P500 52-Week Change 336.19%
52 Week High 30.7800
52 Week Low 30.1100
50-Day Moving Average 30.2807
200-Day Moving Average 30.3764

Share Statistics

Avg Vol (3 month) 3221.96k
Avg Vol (10 day) 3137k
Shares Outstanding 5176.76M
Implied Shares Outstanding 6N/A
Float 120.81M
% Held by Insiders 126.44%
% Held by Institutions 10.14%
Shares Short (Jun. 14, 2021) 448.69k
Short Ratio (Jun. 14, 2021) 40.23
Short % of Float (Jun. 14, 2021) 4N/A
Short % of Shares Outstanding (Jun. 14, 2021) 40.03%
Shares Short (prior month May 13, 2021) 450.13k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,394.30%

Management Effectiveness

Return on Assets (ttm)-14.74%
Return on Equity (ttm)-79.78%

Income Statement

Revenue (ttm)310.33k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)81.60%
Gross Profit (ttm)221.48k
EBITDA -12.96M
Net Income Avi to Common (ttm)-39.11M
Diluted EPS (ttm)-0.2270
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.13M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)564.42k
Total Debt/Equity (mrq)1.89
Current Ratio (mrq)1.74
Book Value Per Share (mrq)0.17

Cash Flow Statement

Operating Cash Flow (ttm)-11.28M
Levered Free Cash Flow (ttm)4.01M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
AUSA.CN
Australis Capital
1 week ago
AUSA.CN
Australis Capital
1 month ago
AUSA.CN
Australis Capital
1 month ago
AUSA.CN
Australis Capital
1 month ago
AUSA.CN
Australis Capital
1 month ago
AUSA.CN
Australis Capital
1 month ago
AUSA.CN
Australis Capital
3 months ago
AUSA.CN
Australis Capital
4 months ago
AUSA.CN
Australis Capital
5 months ago
AUSA.CN
Australis Capital
5 months ago
AUSA.CN
Australis Capital
6 months ago
AUSA.CN
Australis Capital
6 months ago
AUSA.CN
Australis Capital
6 months ago
AUSA.CN
Australis Capital
9 months ago
AUSA.CN
Australis Capital
9 months ago
AUSA.CN
Australis Capital
11 months ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
1 year ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago
AUSA.CN
Australis Capital
2 years ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
26.44%% of Shares Held by All Insider
0.14%% of Shares Held by Institutions
0.19%% of Float Held by Institutions
2Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Australis Capital Inc.


Audacious Acquires LOOS, a California Shot Beverage and Edibles Company

Audacious Acquires LOOS, a California Shot Beverage and Edibles Company

With LOOS, Audacious is adding an exciting new brand and product line to its portfolio aimed at a generally cannabis savvy and influential target market, which cuts across numerous demographics and reaches both the cannacurious and more experienced consumers. Loos' management team brings over a decade of collective experience in cannabi... Read More...
Audacious Brands Enters Massachusetts - Partners with Belle Fleur and Rapper Weed Bringing the Culture Back to the Bay State and Boston

Audacious Brands Enters Massachusetts – Partners with Belle Fleur and Rapper Weed Bringing the Culture Back to the Bay State and Boston

Belle Fleur, founded by the powerhouse cannabis and music industry entrepreneurs behind Californian brand Rapper Weed, Rolandy Romelus, Irvin Whitlow and Domenico Cardarelli, are the holders of a license allowing the development of a Tier 11 high-tech indoor grow facility in Blandford. The Tier 11 license, the largest cultivation license ... Read More...
Australis Corporate Update

Australis Corporate Update

LAS VEGAS, April 29, 2021 -¬†Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") is pleased to provide the following corporate update: Rapid Growth ‚Äď Balance Sheet Strength Jon Paul, CFO, commented, "Despite ALPS only contributing approximately 3 weeks to our year end, AUSA's revenues are anticipated to more than double for the entire... Read More...
Australis Completes First Stage in Green Therapeutics LLC Acquisition

Australis Completes First Stage in Green Therapeutics LLC Acquisition

Transaction Marks Company's Transition to Being a Cannabis Industry Operator Accretive Transaction Adds High-Margin Revenues and Award-Winning Brands Foundational Asset in AUSA's Multi-State Footprint Expansion LAS VEGAS, March 24, 2021 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") today announced that, further to the Company... Read More...
AUSTRALIS Completes Definitive Agreement to Acquire Green Therapeutics LLC

AUSTRALIS Completes Definitive Agreement to Acquire Green Therapeutics LLC

Accretive Transaction Adds High-Margin Revenues and Award-Winning Brands Foundational Asset in AUSA's Multi-State Footprint Acquisition Agreement Includes Resolution of Litigation by Unwinding Original Transaction LAS VEGAS, March 12, 2021 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") today announced that, further to the Comp... Read More...
Australis and 3 Rivers Biotech Enter into Tissue Culture Joint Venture

Australis and 3 Rivers Biotech Enter into Tissue Culture Joint Venture

JV Focused on Commercialization of IP for Commercial Scale Tissue Culture for Cannabis, Hemp and Traditional Crops JV Also Provides Access to other Commercial Ready, Breakthrough Innovations in Pest Control, Pathogen Testing and Genetic Fingerprinting LAS VEGAS, March 3, 2021 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") toda... Read More...
Australis Reports Q3 2021 Results

Australis Reports Q3 2021 Results

On November 17, 2020, an overwhelming majority of attending shareholders voted to support the new leadership team that was proposed by a group of concerned shareholders. Consequently, Dr. Duke Fu, Dr. Jason Dyck, Mr. Avi Geller, Mr. Hanoz Kapadia and Mr. John Esteireiro were elected as Directors of the Company. Dr. Duke Fu also was appoi... Read More...
Australis Completes Definitive Agreement to Acquire 51% Stake in ALPS

Australis Completes Definitive Agreement to Acquire 51% Stake in ALPS

Accretive Transaction Delivers Revenues and Positive Contribution to AUSA EBITDA ALPS Business Accelerating - Contracts Signed in Past 5 Weeks for Total North of $5 Million ALPS Core Element in AUSA's Unique Capital-Light Expansion Strategy Terry Booth to Take the Helm as CEO upon Closing LAS VEGAS, Feb. 24, 2021 - Australis Capital Inc. ... Read More...
Australis Provides Update With Respect to Australian Cannabis Grow Facility Contract

Australis Provides Update With Respect to Australian Cannabis Grow Facility Contract

ALPS and Cann Group Limited sign agreement to confirm and vary facility design, construction management and (post) commissioning services  End-to-End, $2.5 Million Agreement for 363,000 sqft High-Tech Greenhouse Agreement Includes APIS Installation and Ongoing Service Contract LAS VEGAS and MELBOURNE, Australia, Jan. 26, 2021 - Australis... Read More...
Australis To Host Conference Call

Australis To Host Conference Call

Conference Call Participant Numbers Confirmation #: 87780553 Local: 416-764-8659 North American Toll Free:  1-888-664-6392  Webcast URL: http://bitly.ws/b23 About Australis Capital Inc.AUSA is implementing a capital light growth strategy towards establishing a highly competitive and profitable MSO in the U.S.... Read More...
Australis Appoints Financial Leadership Veteran Jon Paul as CFO, Provides Corporate Update

Australis Appoints Financial Leadership Veteran Jon Paul as CFO, Provides Corporate Update

Brings Strong track Record in Cannabis, Consumer and Pharma Industries New Leadership Team Continues to Execute LAS VEGAS, Dec. 30, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") today announces the Company has appointed Jon Paul as its new CFO, effective January 1, 2021. In addition, the Company provides a corporate upda... Read More...
Australis Provides Update

Australis Provides Update

Transition Progressing Smoothly with Rapid Execution out of the Gate LAS VEGAS, Dec. 7, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") is pleased to provide the following corporate update: New Board Rolls Up Their Sleeves and Gets to Work Following overwhelming shareholder support at the November 17, 2020 annual and speci... Read More...
Australis Capital Announces Results of Annual and Special Meeting Of Shareholders - Nominees of the Concerned Shareholders Elected to the Australis Board of Directors

Australis Capital Announces Results of Annual and Special Meeting Of Shareholders – Nominees of the Concerned Shareholders Elected to the Australis Board of Directors

TORONTO, Nov. 18, 2020 - Australis Capital Inc. ("AUSA" or the "Company") (CSE: AUSA) is pleased to announce the results of its annual and special meeting of shareholders held earlier today (the "Meeting") at which approximately 58.8% of the issued and outstanding shares were represented. Prior to the Meeting the director nominees propose... Read More...
Concerned Shareholders Thank Fellow Shareholders for Support and Implore Management to Respect the Will of Shareholders to Enact Change

Concerned Shareholders Thank Fellow Shareholders for Support and Implore Management to Respect the Will of Shareholders to Enact Change

TORONTO, Nov. 13, 2020 - Roger Sykes, 1703469 Alberta Ltd., Duke Fu, Green Therapeutics LLC, Jason Dyck, Terry Booth and Lola Ventures Inc. (the "Concerned Shareholders"), each of whom is a shareholder of Australis Capital Inc. ("Australis" or the "Company") (CSE: AUSA), would like to thank shareholders for the overwhelming support they h... Read More...
Glass Lewis Recommends Australis Shareholders Vote Using Only the Blue Proxy for all Australis Director Nominees

Glass Lewis Recommends Australis Shareholders Vote Using Only the Blue Proxy for all Australis Director Nominees

Notes Dissidents have failed to make a compelling case for change, Express concern that Dissidents may be seeking control of Australis for self-serving purposes Shareholders Urged to Vote FOR Australis' Director Nominees Using Only the BLUE Proxy Card well in advance of the November 13, 2020 11:30 a.m. Mountain Time deadline Contact the... Read More...
CONCERNED SHAREHOLDERS OF AUSTRALIS highlight exorbitant Compensation Grants, CONFUSING ASSESSMENT and SET SIGHTS ON EXPANDED U.S. CANNABIS OPPORTUNITY

CONCERNED SHAREHOLDERS OF AUSTRALIS highlight exorbitant Compensation Grants, CONFUSING ASSESSMENT and SET SIGHTS ON EXPANDED U.S. CANNABIS OPPORTUNITY

Incumbents Continue to Reward Themselves Despite Repeated Failures to Create Value for Shareholders The current Australis board comprised of Harry DeMott and his friends, granted DeMott 7,650,000 options, representing about 4.5% of the current issued and outstanding Australis shares. This was done after issuing former CEO, Scott Dowty, ... Read More...
Leading Independent Proxy Advisor Institutional Shareholder Services Recommends Australis Shareholders Vote Using Only the BLUE Proxy

Leading Independent Proxy Advisor Institutional Shareholder Services Recommends Australis Shareholders Vote Using Only the BLUE Proxy

Notes Dissidents have Failed to make a Compelling Case for Change, that the Board has addressed some of the Dissident Concerns and that new CEO, Harry DeMott, should be given the opportunity to drive the Company's turnaround Momentum continues to build in support of the Australis' Director Nominees Shareholders Urged to Vote FOR Australi... Read More...
Incumbent board and management of Australis resort to desperate attacks in a blatant effort to dismiss the facts and deflect accountability for failed tenure

Incumbent board and management of Australis resort to desperate attacks in a blatant effort to dismiss the facts and deflect accountability for failed tenure

The Incumbents have failed at every turn to advance shareholders' interests and have focused their efforts on deflecting responsibility and resorting to desperate tactics including baseless personal attacks. The Concerned Shareholders simply wish to remind shareholders of the facts. It is the Incumbents' leadership of Australis that has l... Read More...
Australis Shareholders Have Suffered Long Enough. The Concerned Shareholders of AUSTRALIS file and Mail Proxy Circular and Urge Shareholders to Vote for positive change using the Yellow Proxy

Australis Shareholders Have Suffered Long Enough. The Concerned Shareholders of AUSTRALIS file and Mail Proxy Circular and Urge Shareholders to Vote for positive change using the Yellow Proxy

The Concerned Shareholders' proxy circular includes a letter outlining the reasons Australis shareholders should vote FOR the Concerned Shareholders' director nominees, among other matters. Australis shareholders are urged to read the Concerned Shareholders' proxy circular thoroughly and vote with the recommendations of the Concerned Sha... Read More...
Australis Capital Files Proxy Materials and Sends Letter to Shareholders

Australis Capital Files Proxy Materials and Sends Letter to Shareholders

Materials Highlight Management's Strategic Value Creation Plan and Compelling Upside for the Company if Australis' Director Slate is Elected Warns Shareholders that Dissidents Seek Control of the Company, Have a Concerning Growth Plan and History of Self-Enrichment Shareholders Urged to Vote for Australis' Director Nominees Using Only ... Read More...
Australis Capital Delays Filing of Executive Compensation Disclosure

Australis Capital Delays Filing of Executive Compensation Disclosure

LAS VEGAS, Sept. 25, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") announces that it will be relying on the exemption provided in BC Instrument 51-516 ‚ÄĒ Temporary Exemptions from Certain Requirements to File or Send Securityholder Materials (and similar exemptions provided by other relevant Canadian securities regulators... Read More...
Concerned Australis Shareholders Outline Strategy to Grow Core Cannabis Business and Preserve Shareholder Value

Concerned Australis Shareholders Outline Strategy to Grow Core Cannabis Business and Preserve Shareholder Value

Australis shareholders who are supportive of Board change are encouraged to contact Laurel Hill Advisory Group at 1-877-452-7184, or  to register their support. TORONTO, Sept. 24, 2020 - Terry Booth, Lola Ventures Inc., Roger Sykes, 1703469 Alberta Ltd., Duke Fu, Green Therapeutics LLC and Jason Dyck (the "Concerned Shareholders") each... Read More...
Entrenched Australis Board Rejects Settlement Offer and Resorts to Additional Stall Tactics Revealing a Complete Lack of Regard for Australis Shareholders

Entrenched Australis Board Rejects Settlement Offer and Resorts to Additional Stall Tactics Revealing a Complete Lack of Regard for Australis Shareholders

Current board continues to show disturbing trends of self-serving acts, entrenchment, willingness to carelessly spend shareholders' cash and lack of transparency to shareholders Australis shareholders who are supportive of Board change are encouraged to contact Laurel Hill Advisory Group at 1-877-452-7184, or to register their support... Read More...
Cocoon Technology Launches at First of Eight THRIVE Cannabis Marketplace Locations

Cocoon Technology Launches at First of Eight THRIVE Cannabis Marketplace Locations

LAS VEGAS, Sept. 9, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") and its subsidiary Cocoon Technology ("Cocoon") are pleased to announce the installation of CocoonPod self-service kiosks at THRIVE Cannabis Marketplace at 2755 W Cheyenne Ave, 103, North Las Vegas, NV, the first of eight locations operated by THRIVE. The ... Read More...
Australis Board Continues to Protect its Own Interests to the Detriment of Shareholders and Takes Action Only When Compelled by the Concerned Shareholders

Australis Board Continues to Protect its Own Interests to the Detriment of Shareholders and Takes Action Only When Compelled by the Concerned Shareholders

The Concerned Shareholders call on this self-serving, self-interested and self-preserving Board to STAND DOWN to the will of nearly 40% of Australis' shareholders. Other Australis shareholders who are supportive of Board change are encouraged to contact Laurel Hill Advisory Group at 1-877-452-7184, or to register their support. TORON... Read More...
Australis Capital Reaches Settlement Agreement With Passport Technology and Announces Departure of Executive Chairman Scott Dowty

Australis Capital Reaches Settlement Agreement With Passport Technology and Announces Departure of Executive Chairman Scott Dowty

LAS VEGAS, Sept. 3, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") today announced it has reached a settlement agreement (the "Settlement Agreement") with Passport Technology Inc. ("Passport") in respect of the termination of the share purchase agreement (the "Share Purchase Agreement") pursuant to which the Company was t... Read More...
Concerned Australis Shareholders Take Decisive Action to Move Australis Forward by Requisitioning a Shareholder Meeting

Concerned Australis Shareholders Take Decisive Action to Move Australis Forward by Requisitioning a Shareholder Meeting

The incumbent Board continues to engage in transparent delay tactics and appears to be scrambling for new ideas The Concerned Shareholders have a well-advanced strategy to move the company forward and are excited to soon share it with shareholders The Concerned Shareholders, together with other shareholders that have expressed support,... Read More...
Australis Capital Sets Meeting Date, Provides Update Regarding Dialogue with Dissident Shareholders

Australis Capital Sets Meeting Date, Provides Update Regarding Dialogue with Dissident Shareholders

LAS VEGAS, NV, Aug. 20, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") today announced that it has scheduled its annual general and special meeting of shareholders (the "Shareholder Meeting") for November 17, 2020. As previously announced, the Company determined to postpone the previously scheduled Shareholder Meeting in... Read More...
Concerned Australis Shareholders Receive No Response to Settlement Offer, Gain Support of Significant Shareholder and Cannabis Industry Expert Terry Booth and Call for Refreshed Board of Directors

Concerned Australis Shareholders Receive No Response to Settlement Offer, Gain Support of Significant Shareholder and Cannabis Industry Expert Terry Booth and Call for Refreshed Board of Directors

Group of Concerned Australis Shareholders Grows to Include Terry Booth. The Concerned Shareholders propose reconstituting the board with qualified cannabis industry and capital markets professionals, including Mr. Booth, who will execute an effective business strategy for Australis. Shareholders are encouraged to contact Laurel Hill Ad... Read More...
Australis Capital Receives Notice of Dissident Nominees; Will Reschedule Shareholder Meeting

Australis Capital Receives Notice of Dissident Nominees; Will Reschedule Shareholder Meeting

LAS VEGAS, Aug. 10, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("Australis") announces that it has received notice (the "Notice") from Roger Sykes (the "Nominating Shareholder") of its intention to nominate five individuals for election as directors at the Company's upcoming annual general and special meeting of shareholders c... Read More...
Concerned Australis Shareholders Support Termination of Passport Acquisition While Questioning the Path Forward Under Current Leadership

Concerned Australis Shareholders Support Termination of Passport Acquisition While Questioning the Path Forward Under Current Leadership

TORONTO, Aug. 5, 2020 - Roger Sykes, 1703469 Alberta Ltd., Duke Fu and Green Therapeutics LLC, and other concerned shareholders, (the "Concerned Shareholders"), who collectively hold 6.2% of Australis' outstanding common shares, announce their support of the termination of the previously announced acquisition of Passport Technologies Inc.... Read More...
Australis Capital Announces the Termination by Passport Technology of Pending Acquisition Agreement

Australis Capital Announces the Termination by Passport Technology of Pending Acquisition Agreement

LAS VEGAS, Aug. 3, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") announces that it has been informed by Passport Technology, Inc. ("Passport") that Passport has terminated the pending acquisition agreement previously announced by AUSA on June 25, 2020. The terms of the acquisition agreement require Passport to pay a brea... Read More...
Australis Warns That Those Feigning Concern With Passport Transaction Have Selfish Motivations; Their Inaccurate and Misleading Communications Should Not Be Relied on by Australis Shareholders English English

Australis Warns That Those Feigning Concern With Passport Transaction Have Selfish Motivations; Their Inaccurate and Misleading Communications Should Not Be Relied on by Australis Shareholders English English

LAS VEGAS, July 23, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") today warned shareholders about the motivations of a group of shareholders including Roger Sykes ("Sykes") 1703469 Alberta Ltd., Duke Fu, Amy Fu and Green Therapeutics LLC ("Green Therapeutics") (collectively the "Concerned Shareholders"), related to the C... Read More...
Australis Warns That Those Feigning Concern With Passport Transaction Have Selfish Motivations; Their Inaccurate and Misleading Communications Should Not Be Relied on by Australis Shareholders

Australis Warns That Those Feigning Concern With Passport Transaction Have Selfish Motivations; Their Inaccurate and Misleading Communications Should Not Be Relied on by Australis Shareholders

LAS VEGAS, July 23, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") today warned shareholders about the motivations of a group of shareholders including Roger Sykes ("Sykes") 1703469 Alberta Ltd., Duke Fu, Amy Fu and Green Therapeutics LLC ("Green Therapeutics") (collectively the "Concerned Shareholders"), related to the C... Read More...
Coming Soon.

Delayed data (1h)


Share this page